King Pharmaceuticals KG Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | ||
|---|---|---|---|---|---|
| Net premiums earned by Business | |||||
| AmTrust Legacy Segment | $2.29M— | —— | $2.96M+187% | $1.03M— | |
| Diversified Legacy Segment | $867K— | —— | $3.88M+179% | $1.39M— | |
| Legacy Reinsurance | $3.16M-7.6% | $3.42M-50.0% | $6.84M+182% | $2.42M— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does King Pharmaceuticals break its business down?
- King Pharmaceuticals (KG) reports net premiums earned by business across 4 parts — AmTrust Legacy Segment, AmTrust Reinsurance, Diversified Legacy Segment and Legacy Reinsurance. Each is extracted from the segment footnotes and tracked over time.
- Where does King Pharmaceuticals's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in King Pharmaceuticals's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
